March 2023. Volume 19. Number 1

Probiotics were better than placebo or no treatment in preventing upper respiratory tract infections

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Zhao Y, Dong BR, Hao Q. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev. 2022;8(8):CD006895.

Reviewers: Flores Villar S1, Cuestas Montañés EJ2.
1Pediatra. Área de Hospitalización Pediátrica. Hospital Universitario MútuaTerrassa. Barcelona. España.
2Servicio de Pediatría y Neonatología. Hospital Privado Universitario de Córdoba. Córdoba. Argentina.
Correspondence: Sergio Flores Villar. Email: sflores@mutuaterrassa.es
Reception date: 25/01/2023
Acceptance date: 07/02/2023
Publication date: 15/02/2023

Abstract

Authors´ conclusions: when compared to placebo or no treatment, probiotics may reduce the number of participants diagnosed with acute upper respiratory tract infections, may reduce the mean duration of an episode of acute URTIs, likely reduce the number of participants who used antibiotics for URTIs, and may not increase the number of participants who experienced at least one adverse event. The evidence regarding the number of participants who were absent from childcare centre, school, or work due to acute URTIs is very uncertain.

Reviewers´ commentary: according to the results of the meta-analysis, probiotics would be useful for the prevention of acute upper respiratory tract infections and their use could reduce the number of episodes and the number of days of infectious processes.

How to cite this article

Flores Villar S, Cuestas Montañés E. La administración prolongada oral de probióticos podría disminuir la frecuencia de infecciones respiratorias de vías superiores. Evid Pediatr. 2023;19:7.

AVC | Critically appraised articles

Zhao Y, Dong BR, Hao Q. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev. 2022;8(8):CD006895.

Reviewers: Flores Villar S1, Cuestas Montañés EJ2.
1Pediatra. Área de Hospitalización Pediátrica. Hospital Universitario MútuaTerrassa. Barcelona. España.
2Servicio de Pediatría y Neonatología. Hospital Privado Universitario de Córdoba. Córdoba. Argentina.
Correspondence: Sergio Flores Villar. Email: sflores@mutuaterrassa.es
Reception date: 25/01/2023
Acceptance date: 07/02/2023
Publication date: 15/02/2023

How to cite this article

Flores Villar S, Cuestas Montañés E. La administración prolongada oral de probióticos podría disminuir la frecuencia de infecciones respiratorias de vías superiores. Evid Pediatr. 2023;19:7.

15/02/2023

Linked Comment